ChemicalBook > CAS DataBase List > 5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide

5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide

Product Name
5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide
CAS No.
406191-34-2
Chemical Name
5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide
Synonyms
BCATc Inhibitor 2;BCATc Inhibitor 2, 10 mM in DMSO;5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide;2-Benzofurancarboxylic acid, 5-chloro-, 2-[[2-(trifluoromethyl)phenyl]sulfonyl]hydrazide;cytosolic,neurodegenerative,human,BCATc Inhibitor-2,mitochondrial,disease,rBCATc,Inhibitor,BCAT,BCATc Inhibitor 2,rBCATm,inhibit,hBCATc,BCATc Inhibitor2
CBNumber
CB13622657
Molecular Formula
C16H10ClF3N2O4S
Formula Weight
418.7748096
MOL File
406191-34-2.mol
More
Less

5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide Property

storage temp. 
Store at -20°C, protect from light
solubility 
≤10mg/ml in ethanol;20mg/ml in DMSO;25mg/ml in dimethyl formamide
form 
crystalline solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
9002002
Product name
BCATc Inhibitor 2
Purity
≥98%
Packaging
1mg
Price
$44
Updated
2024/03/01
Cayman Chemical
Product number
9002002
Product name
BCATc Inhibitor 2
Purity
≥98%
Packaging
5mg
Price
$193
Updated
2024/03/01
Cayman Chemical
Product number
9002002
Product name
BCATc Inhibitor 2
Purity
≥98%
Packaging
10mg
Price
$341
Updated
2024/03/01
Cayman Chemical
Product number
9002002
Product name
BCATc Inhibitor 2
Purity
≥98%
Packaging
50mg
Price
$1169
Updated
2024/03/01
ApexBio Technology
Product number
C3463
Product name
BCATcInhibitor2
Packaging
50mg
Price
$1336
Updated
2021/12/16
More
Less

5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide Chemical Properties,Usage,Production

Biological Activity

bcatc inhibitor 2 is an active and selective inhibitor of cytosolic bcat (bcatc)[1].branched-chain amino acid transferases (bcats) have been implicated in catalyzing reversible transamination of isoleucine, leucine, and valine branched-chain amino acids to their corresponding α-keto acids, generating l-glutamate. it has been identified that there are two forms of bcat in mammals: mitochondrial bcat (bcatm) and cytosolic bcat (bcatc). bcatc is expressed in particular brain region and involved in regulating glutamate synthesis for release during neuronal excitation. thus, bcatc inhibition may be useful for the treatment of neurodegenerative and behavioral disorders involving disturbances of the glutamatergic system [2].

in vitro

bcatc inhibition is likely to be useful for the treatment of neurodegenerative and other neurological disorders involving disturbances of the glutamatergic system. in the hbcatc assays, bcatc inhibitor 2 exhibited an ic50 of 0.8 ± 0.05 μm. in a recombinant rat bcatc assay and a crude rat bcatm assay, the ic50 was 0.2 μm ± 0.02 and 3.0 μm ± 0.5 (n=5), respectively. bcatc inhibitor 2 decreased calcium influx in neuronal cultures with an ic50 of 4.8 ± 1.2 μm (n=4) [1].

in vivo

bcatc inhibitor 2 blocked calcium influx into neuronal cells following inhibition of glutamate uptake, and demonstrated neuroprotective efficacy in vivo. in lewis rats, after treatment with 30 mg/kg bcatc inhibitor 2 (subcutaneous injection), the peak plasma concentration (cmax) reached 8.28 μg/ml at 0.5 h (tmax). the mean plasma exposure (auc) value was 19.9 μg h/ml, and the mean terminal half-life ranged from 12 to 15 h, indicating favorable pk parameters of bcatc inhibitor 2. daily administration of the mitochondrial neurotoxin, 3-nitroproprionic acid (3-np) produced striatal lesions and led to motor deficits. administration of bcatc inhibitor 2 for 9 days almost completely reversed the effects of 3-np [1].

References

[1] hu l y, boxer p a, kesten s r, et al. the design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases[j]. bioorganic & medicinal chemistry letters, 2006, 16(9): 2337-2340.
[2] brosnan j t, brosnan m e. branched-chain amino acids: enzyme and substrate regulation[j]. the journal of nutrition, 2006, 136(1): 207s-211s.

5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide Suppliers

Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9804
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
7323
Advantage
58
MQ (shanghai) Pharmaceuticals Co., Ltd.
Tel
13761635123
Fax
1014988033@qq
Email
1014988033@qq.com
Country
China
ProdList
4999
Advantage
55
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32161
Advantage
58
Shanghai Dongyang Biotechnology Co., Ltd.
Tel
0512-0512-13601744364 13601744364
Email
chemsharker@126.com
Country
China
ProdList
936
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
MedBioPharmaceutical Technology Inc
Tel
021-69568360 18916172912
Email
order@med-bio.cn
Country
China
ProdList
8140
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 15801484223;
Email
psaitong@jm-bio.com
Country
China
ProdList
29774
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24644
Advantage
58
Nanjing Tengyi Biotechnology Co., Ltd
Tel
025-58851786 17714337195
Email
sales@tybiochem.com
Country
China
ProdList
6830
Advantage
58

406191-34-2, 5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazideRelated Search:


  • 5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide
  • BCATc Inhibitor 2
  • 2-Benzofurancarboxylic acid, 5-chloro-, 2-[[2-(trifluoromethyl)phenyl]sulfonyl]hydrazide
  • cytosolic,neurodegenerative,human,BCATc Inhibitor-2,mitochondrial,disease,rBCATc,Inhibitor,BCAT,BCATc Inhibitor 2,rBCATm,inhibit,hBCATc,BCATc Inhibitor2
  • BCATc Inhibitor 2, 10 mM in DMSO
  • 406191-34-2